{"title": "Terapia con vacunas en el tratamiento de pacientes con c\u00e1ncer de colon, p\u00e1ncreas o pulm\u00f3n", "author": null, "url": "https://ichgcp.net/es/clinical-trials-registry/NCT00019006", "hostname": "ichgcp.net", "description": "FUNDAMENTO: Las vacunas elaboradas a partir de p\u00e9ptidos ras mutados pueden hacer que el cuerpo genere una respuesta inmunitaria y destruya las c\u00e9lulas tumorales.... Registro de ensayos cl\u00ednicos. ICH GCP.", "sitename": "ichgcp.net", "date": "2007-03-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Terapia con vacunas en el tratamiento de pacientes con c\u00e1ncer de colon, p\u00e1ncreas o pulm\u00f3n\n[National Cancer Institute (NCI)](https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%20Cancer%20Institute%20%28NCI%29)\nEstudio piloto de fase I de la terapia con vacunas con p\u00e9ptidos Ras mutados espec\u00edficos de tumores en el entorno adyuvante en pacientes con c\u00e1ncer colorrectal, pancre\u00e1tico o de pulm\u00f3n\nFUNDAMENTO: Las vacunas elaboradas a partir de p\u00e9ptidos ras mutados pueden hacer que el cuerpo genere una respuesta inmunitaria y destruya las c\u00e9lulas tumorales.\nPROP\u00d3SITO: Ensayo de fase I para estudiar la eficacia de una vacuna que contiene p\u00e9ptidos ras mutados y un adyuvante inmunitario en el tratamiento de pacientes con c\u00e1ncer de colon, p\u00e1ncreas o pulm\u00f3n.\nDescripci\u00f3n general del estudio\nEstado\nCondiciones\n-\n[C\u00e1ncer de p\u00e1ncreas recurrente](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Recurrent%20Pancreatic%20Cancer)\n-\n[C\u00e1ncer de p\u00e1ncreas en estadio III](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20III%20Pancreatic%20Cancer)\n-\n[C\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as en estadio extenso](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Extensive%20Stage%20Small%20Cell%20Lung%20Cancer)\n-\n[C\u00e1ncer de colon recurrente](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Recurrent%20Colon%20Cancer)\n-\n[C\u00e1ncer de recto recurrente](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Recurrent%20Rectal%20Cancer)\n-\n[C\u00e1ncer de p\u00e1ncreas en estadio II](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20II%20Pancreatic%20Cancer)\n-\n[C\u00e1ncer de p\u00e1ncreas en estadio IVA](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20IVA%20Pancreatic%20Cancer)\n-\n[C\u00e1ncer de p\u00e1ncreas en estadio IVB](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20IVB%20Pancreatic%20Cancer)\n-\n[C\u00e1ncer de p\u00e1ncreas en estadio I](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20I%20Pancreatic%20Cancer)\n-\n[C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as en estadio II](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20II%20Non-small%20Cell%20Lung%20Cancer)\n-\n[C\u00e1ncer de colon en estadio III](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20III%20Colon%20Cancer)\n-\n[C\u00e1ncer de recto en estadio III](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20III%20Rectal%20Cancer)\n-\n[C\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as en etapa limitada](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Limited%20Stage%20Small%20Cell%20Lung%20Cancer)\n-\n[C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as en estadio III](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20III%20Non-small%20Cell%20Lung%20Cancer)\nIntervenci\u00f3n / Tratamiento\nDescripci\u00f3n detallada\nOBJETIVOS: I. Determinar si la inmunidad humoral o celular end\u00f3gena a una prote\u00edna ras mutada espec\u00edfica de tumor est\u00e1 presente en pacientes con c\u00e1ncer colorrectal, pancre\u00e1tico o de pulm\u00f3n.\nII. Determinar si la vacunaci\u00f3n con un p\u00e9ptido sint\u00e9tico correspondiente a la mutaci\u00f3n ras del tumor combinada con el adyuvante Detox-B puede inducir o potenciar la inmunidad celular a esa mutaci\u00f3n particular en esta poblaci\u00f3n de pacientes.\ntercero Determinar el tipo y caracter\u00edsticas de la posible inmunidad celular generada en estos pacientes tratados con este r\u00e9gimen.\nIV. Determinar los espectros de tolerancia y toxicidad de dichos p\u00e9ptidos administrados con el adyuvante Detox-B en estos pacientes.\nV. Determinar la respuesta inmune asociada a cada dosis de p\u00e9ptido en estos pacientes.\nVI. Evaluar cualquier respuesta tumoral que pueda ocurrir con el tratamiento en estos pacientes tratados con este r\u00e9gimen.\nESQUEMA DEL PROTOCOLO: Este es un estudio de escalada de dosis. Los pacientes reciben p\u00e9ptido ras mutado espec\u00edfico del tumor combinado con adyuvante Detox-B por v\u00eda subcut\u00e1nea mensualmente durante 3 meses. El tratamiento contin\u00faa en ausencia de progresi\u00f3n de la enfermedad o toxicidad inaceptable. Los pacientes con enfermedad estable o que responde o con una respuesta inmunol\u00f3gica espec\u00edfica pueden recibir 3 vacunas mensuales adicionales.\nCohortes de 3 a 6 pacientes reciben dosis crecientes de p\u00e9ptido ras mutado espec\u00edfico del tumor combinado con adyuvante Detox-B hasta que se determina la dosis m\u00e1xima tolerada (MTD). La MTD se define como la dosis anterior a la que 2 de 3 o 2 de 6 pacientes experimentan toxicidad limitante de la dosis.\nACUMULACI\u00d3N PROYECTADA:\nSe acumular\u00e1 un total de 33 pacientes (12 en el entorno adyuvante) para este estudio dentro de los 12 meses.\nTipo de estudio\nFase\n- Fase 1\nContactos y Ubicaciones\nUbicaciones de estudio\n-\nEstados Unidos\n-\nMaryland\n-\nBethesda, Maryland, Estados Unidos, 20892\n- Medicine Branch\n-\n-\nCriterios de participaci\u00f3n\nCriterio de elegibilidad\nEdades elegibles para estudiar\nAcepta Voluntarios Saludables\nDescripci\u00f3n\nDiagn\u00f3stico confirmado histopatol\u00f3gicamente de histiocitosis de c\u00e9lulas de Langerhans seg\u00fan los criterios definidos por la Histiocyte Society\n- Demostraci\u00f3n de determinantes antig\u00e9nicos CD1a en la superficie de c\u00e9lulas lesionadas (por inmunocitolog\u00eda o inmunohistolog\u00eda) o gr\u00e1nulos de Birbeck en c\u00e9lulas lesionadas por microscop\u00eda electr\u00f3nica\nConsiderado en riesgo o bajo riesgo de acuerdo con los siguientes criterios:\nEnfermedad multisist\u00e9mica en riesgo, definida como la afectaci\u00f3n de uno o m\u00e1s \u00f3rganos de riesgo (es decir, sistema hematopoy\u00e9tico, h\u00edgado, bazo o pulmones)\n- Sin compromiso pulmonar de un solo sistema\nEnfermedad multisist\u00e9mica de bajo riesgo\n- M\u00faltiples \u00f3rganos comprometidos pero sin compromiso de \u00f3rganos de riesgo\nEnfermedad de un solo sistema\n- Enfermedad \u00f3sea multifocal (es decir, lesiones en 2 o m\u00e1s huesos diferentes)\nCompromiso localizado en un sitio especial, como lesiones de riesgo para el SNC con extensi\u00f3n intracraneal a los tejidos blandos o lesiones vertebrales con extensi\u00f3n intraespinal a los tejidos blandos\n- Las lesiones de la b\u00f3veda no se consideran lesiones de riesgo para el SNC\nCRITERIOS DE ENTRADA DEL PROTOCOLO:\n--Caracter\u00edsticas de la enfermedad-- Tumor s\u00f3lido documentado histol\u00f3gicamente que expresa potencialmente ras mutante Adenocarcinoma de pulm\u00f3n en estadio II/III despu\u00e9s de cirug\u00eda o radioterapia C\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as limitado o extenso en remisi\u00f3n completa C\u00e1ncer colorrectal Dukes C despu\u00e9s de quimioterapia adyuvante adecuada Carcinoma colorrectal recurrente completamente resecado Carcinoma pancre\u00e1tico completamente resecado Tejido tumoral disponible para la determinaci\u00f3n de la mutaci\u00f3n ras Bloque de parafina o tejido fresco Se requiere una mutaci\u00f3n puntual espec\u00edfica en el cod\u00f3n 12, que incluye: Glicina a ciste\u00edna Glicina a \u00e1cido asp\u00e1rtico Glicina a valina Tejido tumoral disponible para la preparaci\u00f3n de una l\u00ednea de c\u00e9lulas tumorales y un tumor o tejido de ganglios linf\u00e1ticos para la expansi\u00f3n de linfocitos que infiltran el tumor para estudios de laboratorio in vitro preferidos Sin antecedentes de met\u00e1stasis en el SNC --Terapia previa/concurrente-- Terapia biol\u00f3gica: al menos 4 semanas desde la inmunoterapia previa y la quimioterapia recuperada: ver Caracter\u00edsticas de la enfermedad Al menos 4 semanas desde quimioterapia previa y terapia endocrina recuperada: Al menos 4 semanas desde esteroides previos y radioterapia recuperada: Al menos 4 semanas desde radioterapia previa y cirug\u00eda recuperada: Ver Caracter\u00edsticas de la enfermedad No especificado --Caracter\u00edsticas del paciente-- Edad: Mayor de 18 Estado funcional: ECOG 0 -1 Esperanza de vida: M\u00e1s de 3 meses Hematopoy\u00e9tico: WBC al menos 3000/mm3 Recuento de linfocitos al menos 600/mm3 Recuento de plaquetas al menos 100 000/mm3 Hep\u00e1tico: Bilirrubina no superior a 2,0 mg/dL ALT y AST no superior a 4 veces lo normal Ant\u00edgeno de superficie de hepatitis B y C negativo Renal: Creatinina no superior a 2,0 mg/dL Cardiovascular: Sin cardiopat\u00eda isqu\u00e9mica activa (clase III/IV de la New York Heart Association) Sin infarto de miocardio en los \u00faltimos 6 meses Sin antecedentes de arritmia Sin s\u00edntomas cl\u00ednicos que sugieran insuficiencia card\u00edaca Pulmonar: Sin s\u00edntomas cl\u00ednicos que sugieran insuficiencia pulmonar Inmunol\u00f3gico: Responde a pruebas cut\u00e1neas de anergia con paperas, trichophyton o ant\u00edgenos de candida VIH negativo Sin enfermedad autoinmune, por ejemplo: Lupus eritematoso sist\u00e9mico Esclerosis m\u00faltiple Espondilitis anquilosante Otro: Sin infecci\u00f3n activa que requiera antibi\u00f3ticos Carcinoma de piel de c\u00e9lulas basales tratado curativamente o carcinoma in situ del cuello uterino tratado curativamente No embarazada o lactante Prueba de embarazo negativa Las pacientes f\u00e9rtiles deben usar m\u00e9todos anticonceptivos efectivos\nPlan de estudios\n\u00bfC\u00f3mo est\u00e1 dise\u00f1ado el estudio?\nDetalles de dise\u00f1o\n- Prop\u00f3sito principal: Tratamiento\nColaboradores e Investigadores\nPatrocinador\nInvestigadores\n- Silla de estudio: Samir N. Khleif, National Cancer Institute (NCI)\nFechas de registro del estudio\nFechas importantes del estudio\nInicio del estudio\nFechas de registro del estudio\nEnviado por primera vez\nPrimero enviado que cumpli\u00f3 con los criterios de control de calidad\nPublicado por primera vez (Estimar)\nActualizaciones de registros de estudio\n\u00daltima actualizaci\u00f3n publicada (Estimar)\n\u00daltima actualizaci\u00f3n enviada que cumpli\u00f3 con los criterios de control de calidad\n\u00daltima verificaci\u00f3n\nM\u00e1s informaci\u00f3n\nT\u00e9rminos relacionados con este estudio\nPalabras clave\n-\n[c\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as en estadio extenso](https://ichgcp.net/es/clinical-trials-registry/research/list?term=extensive%20stage%20small%20cell%20lung%20cancer)\n-\n[c\u00e1ncer colonrectal](https://ichgcp.net/es/clinical-trials-registry/research/list?term=colorectal%20cancer)\n-\n[c\u00e1ncer de colon recurrente](https://ichgcp.net/es/clinical-trials-registry/research/list?term=recurrent%20colon%20cancer)\n-\n[c\u00e1ncer de recto recurrente](https://ichgcp.net/es/clinical-trials-registry/research/list?term=recurrent%20rectal%20cancer)\n-\n[c\u00e1ncer de pulm\u00f3n](https://ichgcp.net/es/clinical-trials-registry/research/list?term=lung%20cancer)\n-\n[c\u00e1ncer](https://ichgcp.net/es/clinical-trials-registry/research/list?term=cancer)\n-\n[c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as](https://ichgcp.net/es/clinical-trials-registry/research/list?term=non-small%20cell%20lung%20cancer)\n-\n[C\u00e1ncer de recto](https://ichgcp.net/es/clinical-trials-registry/research/list?term=rectal%20cancer)\n-\n[c\u00e1ncer de p\u00e1ncreas recurrente](https://ichgcp.net/es/clinical-trials-registry/research/list?term=recurrent%20pancreatic%20cancer)\n-\n[c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as en estadio II](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20II%20non-small%20cell%20lung%20cancer)\n-\n[c\u00e1ncer de colon en estadio III](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20III%20colon%20cancer)\n-\n[c\u00e1ncer de colon](https://ichgcp.net/es/clinical-trials-registry/research/list?term=colon%20cancer)\n-\n[Cancer de pancreas](https://ichgcp.net/es/clinical-trials-registry/research/list?term=pancreatic%20cancer)\n-\n[tumor s\u00f3lido adulto](https://ichgcp.net/es/clinical-trials-registry/research/list?term=adult%20solid%20tumor)\n-\n[tumor solido](https://ichgcp.net/es/clinical-trials-registry/research/list?term=solid%20tumor)\n-\n[c\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as en etapa limitada](https://ichgcp.net/es/clinical-trials-registry/research/list?term=limited%20stage%20small%20cell%20lung%20cancer)\n-\n[c\u00e1ncer de p\u00e1ncreas en estadio IV](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20IV%20pancreatic%20cancer)\n-\n[c\u00e1ncer gastrointestinal](https://ichgcp.net/es/clinical-trials-registry/research/list?term=gastrointestinal%20cancer)\n-\n[c\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as](https://ichgcp.net/es/clinical-trials-registry/research/list?term=small%20cell%20lung%20cancer)\n-\n[sistema del cuerpo/c\u00e1ncer de sitio](https://ichgcp.net/es/clinical-trials-registry/research/list?term=body%20system%2Fsite%20cancer)\n-\n[c\u00e1ncer de recto en estadio III](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20III%20rectal%20cancer)\n-\n[c\u00e1ncer de p\u00e1ncreas en estadio III](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20III%20pancreatic%20cancer)\n-\n[c\u00e1ncer de p\u00e1ncreas en estadio I](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20I%20pancreatic%20cancer)\n-\n[c\u00e1ncer de p\u00e1ncreas en estadio II](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20II%20pancreatic%20cancer)\n-\n[condici\u00f3n gen\u00e9tica](https://ichgcp.net/es/clinical-trials-registry/research/list?term=genetic%20condition)\n-\n[c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as en estadio III](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20III%20non-small%20cell%20lung%20cancer)\n-\n[c\u00e1ncer de p\u00e1ncreas en estadio IVA](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20IVA%20pancreatic%20cancer)\n-\n[c\u00e1ncer de p\u00e1ncreas en estadio IVB](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20IVB%20pancreatic%20cancer)\n-\n[etapa, c\u00e1ncer de colon](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20colon%20cancer)\n-\n[etapa, c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20non-small%20cell%20lung%20cancer)\n-\n[etapa, c\u00e1ncer de p\u00e1ncreas](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20pancreatic%20cancer)\n-\n[etapa, c\u00e1ncer de recto](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20rectal%20cancer)\n-\n[etapa, c\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as](https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20small%20cell%20lung%20cancer)\n-\n[c\u00e1ncer de t\u00f3rax/respiratorio](https://ichgcp.net/es/clinical-trials-registry/research/list?term=thorax%2Frespiratory%20cancer)\nT\u00e9rminos MeSH relevantes adicionales\n-\n[Enfermedades del Sistema Digestivo](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Digestive%20System%20Diseases)\n-\n[Procesos Patol\u00f3gicos](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pathologic%20Processes)\n-\n[Enfermedades de las v\u00edas respiratorias](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Diseases)\n-\n[Neoplasias](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms)\n-\n[Enfermedades pulmonares](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Lung%20Diseases)\n-\n[Neoplasias por sitio](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms%20by%20Site)\n-\n[Enfermedades del sistema endocrino](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Endocrine%20System%20Diseases)\n-\n[Atributos de la enfermedad](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Disease%20Attributes)\n-\n[Neoplasias Gastrointestinales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Gastrointestinal%20Neoplasms)\n-\n[Neoplasias del Sistema Digestivo](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Digestive%20System%20Neoplasms)\n-\n[Enfermedades Gastrointestinales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Gastrointestinal%20Diseases)\n-\n[Neoplasias de gl\u00e1ndulas endocrinas](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Endocrine%20Gland%20Neoplasms)\n-\n[Neoplasias de las v\u00edas respiratorias](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Neoplasms)\n-\n[Neoplasias tor\u00e1cicas](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Thoracic%20Neoplasms)\n-\n[Carcinoma Broncog\u00e9nico](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%2C%20Bronchogenic)\n-\n[Neoplasias Bronquiales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Bronchial%20Neoplasms)\n-\n[Enfermedades del Colon](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colonic%20Diseases)\n-\n[Enfermedades intestinales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Intestinal%20Diseases)\n-\n[Neoplasias Intestinales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Intestinal%20Neoplasms)\n-\n[Enfermedades Rectales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Rectal%20Diseases)\n-\n[Neoplasias colorrectales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colorectal%20Neoplasms)\n-\n[Enfermedades pancre\u00e1ticas](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pancreatic%20Diseases)\n-\n[Neoplasias Pulmonares](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Lung%20Neoplasms)\n-\n[Carcinoma de pulm\u00f3n de c\u00e9lulas no peque\u00f1as](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%2C%20Non-Small-Cell%20Lung)\n-\n[Reaparici\u00f3n](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Recurrence)\n-\n[Neoplasias Rectales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Rectal%20Neoplasms)\n-\n[Carcinoma de pulm\u00f3n de c\u00e9lulas peque\u00f1as](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Small%20Cell%20Lung%20Carcinoma)\n-\n[Neoplasias pancre\u00e1ticas](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pancreatic%20Neoplasms)\n-\n[Neoplasias col\u00f3nicas](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colonic%20Neoplasms)\n-\n[Efectos fisiol\u00f3gicos de las drogas](https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Physiological%20Effects%20of%20Drugs)\n-\n[Factores inmunol\u00f3gicos](https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Immunologic%20Factors)\n-\n[Adyuvantes, Inmunol\u00f3gicos](https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Adjuvants%2C%20Immunologic)\n-\n[Adyuvante de desintoxicaci\u00f3n](https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Detox%20adjuvant)\nOtros n\u00fameros de identificaci\u00f3n del estudio\n- CDR0000063475\n- NCI-94-C-0096D\n- NCI-T93-0152N\nEsta informaci\u00f3n se obtuvo directamente del sitio web\n[clinicaltrials.gov](https://clinicaltrials.gov) sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comun\u00edquese con [register@clinicaltrials.gov](mailto:register@clinicaltrials.gov). Tan pronto como se implemente un cambio en [clinicaltrials.gov](https://clinicaltrials.gov), tambi\u00e9n se actualizar\u00e1 autom\u00e1ticamente en nuestro sitio web. .\nEnsayos cl\u00ednicos sobre C\u00e1ncer de p\u00e1ncreas recurrente\n-\nNCT05895214A\u00fan no reclutandoCirug\u00eda | PDAC | Pancreatoduodenectom\u00eda | Margen, Resecci\u00f3n | Tumor recurrente local\n-\nNCT05848739ReclutamientoCarcinoma hepatocelular | Cancer de pancreas | C\u00e1ncer de ovarios | Colangiocarcinoma | C\u00e1ncer de mama triple negativo | Melanoma metast\u00e1sico | C\u00e1ncer de colon | Sarcoma sinovial | C\u00e1ncer de mama metast\u00e1sico | C\u00e1ncer de colon metast\u00e1sico\n-\nNCT05736731Reclutamiento\n[Un estudio para evaluar la seguridad y eficacia de A2B530, un CAR T activado por l\u00f3gica, en sujetos con tumores s\u00f3lidos que expresan CEA y han perdido la expresi\u00f3n de HLA-A*02 (EVEREST-1)](https://ichgcp.net/es/clinical-trials-registry/NCT05736731)C\u00e1ncer | Neoplasias colorrectales | C\u00e1ncer colonrectal | Neoplasias pancre\u00e1ticas | Cancer de pancreas | NSCLC | Tumor solido | C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as | C\u00e1ncer colorrectal metast\u00e1sico | C\u00e1ncer de p\u00e1ncreas\n-\nNCT05415475Reclutamiento\n[Estudio cl\u00ednico de terapia CAR-T dirigida a CEA para tumores s\u00f3lidos malignos avanzados positivos para CEA](https://ichgcp.net/es/clinical-trials-registry/NCT05415475)C\u00e1ncer de est\u00f3mago | C\u00e1ncer colonrectal | Cancer de pancreas | C\u00e1ncer de es\u00f3fago | C\u00e1ncer recurrente | Tumor metast\u00e1sico\n-\nNCT05396300Reclutamiento\n[Un estudio cl\u00ednico de CAR-T dirigido a CEA en el tratamiento de tumores s\u00f3lidos malignos avanzados CEA positivos](https://ichgcp.net/es/clinical-trials-registry/NCT05396300)C\u00e1ncer de est\u00f3mago | C\u00e1ncer colonrectal | Cancer de pancreas | C\u00e1ncer de es\u00f3fago | C\u00e1ncer recurrente | Tumor metast\u00e1sico\n-\nNCT05360264Reclutamiento\n[Reutilizaci\u00f3n de medicamentos a la medida de la decitabina en el c\u00e1ncer de p\u00e1ncreas refractario dependiente de KRAS (ORIENTATE)](https://ichgcp.net/es/clinical-trials-registry/NCT05360264)Adenocarcinoma de p\u00e1ncreas metast\u00e1sico | Adenocarcinoma de p\u00e1ncreas recurrente\n-\nNCT05238831A\u00fan no reclutandoC\u00e1ncer de mama anat\u00f3mico en estadio III AJCC v8 | Carcinoma de ovario recurrente | C\u00e1ncer de mama anat\u00f3mico en estadio IV AJCC v8 | Neoplasia s\u00f3lida maligna avanzada | Carcinoma pancre\u00e1tico avanzado | C\u00e1ncer de p\u00e1ncreas en estadio II AJCC v8 | C\u00e1ncer de p\u00e1ncreas en estadio III AJCC v8 | C\u00e1ncer de p\u00e1ncreas en estadio IV AJCC v8 | Carcinoma de mama recurrente | Carcinoma de pr\u00f3stata recurrente\n-\nNCT04907643Reclutamiento\n[Realidad virtual para el dolor del c\u00e1ncer GI para mejorar los resultados informados por los pacientes](https://ichgcp.net/es/clinical-trials-registry/NCT04907643)Neoplasias Gastrointestinales | C\u00e1ncer de est\u00f3mago | C\u00e1ncer de intestino delgado | C\u00e1ncer de recto | Tumor neuroendocrino | C\u00e1ncer de las v\u00edas biliares | C\u00e1ncer de colon | C\u00e1ncer de p\u00e1ncreas | C\u00e1ncer de ano | C\u00e1ncer de h\u00edgado\n-\nNCT04902261ReclutamientoC\u00e1ncer de p\u00e1ncreas recurrente\n-\nNCT04889742ReclutamientoSarcoma | C\u00e1ncer de cuello uterino | C\u00e1ncer de es\u00f3fago | C\u00e1ncer de recto | Cancer de prostata | Tumores neuroendocrinos | C\u00e1ncer de p\u00e1ncreas | C\u00e1ncer de ano | Carcinoma de c\u00e9lulas escamosas | C\u00e1ncer recurrente\nEnsayos cl\u00ednicos sobre Adyuvante Detox-B\n-\nNCT00002767Desconocido\n-\nNCT00007969Terminado\n-\nNCT00003638Terminado", "language": null, "image": null, "pagetype": "website", "links": ["https://ichgcp.net/es", "#", "https://ichgcp.net/de", "https://ichgcp.net/", "https://ichgcp.net/es", "https://ichgcp.net/fr", "https://ichgcp.net/it", "https://ichgcp.net/pt", "https://ichgcp.net/ru", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/ich-e-group-of-guidelines", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/events", "https://ichgcp.net/es/clinical-trials-registry/publications", "https://ichgcp.net/es/clinical-trials-registry/researchers", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/clinical-trials-registry/NCT00019006", "https://telegram.me/share/url?url=https://ichgcp.net/es/clinical-trials-registry/NCT00019006&text=", "https://twitter.com/intent/tweet?url=https://ichgcp.net/es/clinical-trials-registry/NCT00019006", "https://ichgcp.net/es", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%20Cancer%20Institute%20%28NCI%29", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Recurrent%20Pancreatic%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20III%20Pancreatic%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Extensive%20Stage%20Small%20Cell%20Lung%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Recurrent%20Colon%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Recurrent%20Rectal%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20II%20Pancreatic%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20IVA%20Pancreatic%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20IVB%20Pancreatic%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20I%20Pancreatic%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20II%20Non-small%20Cell%20Lung%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20III%20Colon%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20III%20Rectal%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Limited%20Stage%20Small%20Cell%20Lung%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%20III%20Non-small%20Cell%20Lung%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Detox-B%20adjuvant", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=ras%20peptide%20cancer%20vaccine", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%20Cancer%20Institute%20%28NCI%29", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=extensive%20stage%20small%20cell%20lung%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=colorectal%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=recurrent%20colon%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=recurrent%20rectal%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=lung%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=non-small%20cell%20lung%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=rectal%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=recurrent%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20II%20non-small%20cell%20lung%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20III%20colon%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=colon%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=adult%20solid%20tumor", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=solid%20tumor", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=limited%20stage%20small%20cell%20lung%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20IV%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=gastrointestinal%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=small%20cell%20lung%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=body%20system%2Fsite%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20III%20rectal%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20III%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20I%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20II%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=genetic%20condition", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20III%20non-small%20cell%20lung%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20IVA%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20IVB%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20colon%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20non-small%20cell%20lung%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20rectal%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%2C%20small%20cell%20lung%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=thorax%2Frespiratory%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Digestive%20System%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pathologic%20Processes", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Lung%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms%20by%20Site", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Endocrine%20System%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Disease%20Attributes", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Gastrointestinal%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Digestive%20System%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Gastrointestinal%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Endocrine%20Gland%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Thoracic%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%2C%20Bronchogenic", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Bronchial%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colonic%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Intestinal%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Intestinal%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Rectal%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colorectal%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pancreatic%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Lung%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%2C%20Non-Small-Cell%20Lung", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Recurrence", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Rectal%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Small%20Cell%20Lung%20Carcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pancreatic%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colonic%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Physiological%20Effects%20of%20Drugs", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Immunologic%20Factors", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Adjuvants%2C%20Immunologic", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Detox%20adjuvant", "https://clinicaltrials.gov", "mailto:register@clinicaltrials.gov", "https://clinicaltrials.gov", "https://ichgcp.net/es/clinical-trials-registry/NCT05895214", "https://ichgcp.net/es/clinical-trials-registry/NCT05848739", "https://ichgcp.net/es/clinical-trials-registry/NCT05736731", "https://ichgcp.net/es/clinical-trials-registry/NCT05415475", "https://ichgcp.net/es/clinical-trials-registry/NCT05396300", "https://ichgcp.net/es/clinical-trials-registry/NCT05360264", "https://ichgcp.net/es/clinical-trials-registry/NCT05238831", "https://ichgcp.net/es/clinical-trials-registry/NCT04907643", "https://ichgcp.net/es/clinical-trials-registry/NCT04902261", "https://ichgcp.net/es/clinical-trials-registry/NCT04889742", "https://ichgcp.net/es/clinical-trials-registry/NCT00002767", "https://ichgcp.net/es/clinical-trials-registry/NCT00007969", "https://ichgcp.net/es/clinical-trials-registry/NCT00003638", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Center%2Bfor%2BIndustrial%2BTechnological%2BDevelopment%2Bof%2BSpain", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Mayo%2BClinic", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=M.D.%2BAnderson%2BCancer%2BCenter", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Cairo%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Kaneka%2BAmericas%2BHolding%2BInc.", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assistance%2BPublique%2B-%2BH%25C3%25B4pitaux%2Bde%2BParis", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Medtronic%2BSurgical%2BTechnologies", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Orphanetics%2BPharma%2BEntwicklungs%2BGmbH", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=GlaxoSmithKline", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidade%2Bde%2BLisboa%252C%2BPortugal", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pfizer", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=AstraZeneca", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pediatric%2BOrthopaedic%2BSociety%2Bof%2BNorth%2BAmerica", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%2BCancer%2BInstitute%2B%2528NCI%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Novartis%2BPharmaceuticals", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Jos%25C3%25A9phine%2BSOLTANI%252C%2BCardiology%2Bdepartment%252C%2BVersailles%2BHospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidad%2Bdel%2BZulia", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=SeeCure%2BLLC", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=European%2BSociety%2Bof%2BHuman%2BReproduction%2Band%2BEmbryology", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assiut%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%2BI%2BGallbladder%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Esophageal%2BResection%2BCandidates", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=HIV%2BInfections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Malignant%2BNeoplasm%2Bof%2BRespiratory%2Band%2BIntrathoracic%2BOrgan%2BCarcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Postneoadjuvant%2BTherapy%2BStage%2BI%2BGastric%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Obesity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ankle%2BArthroplasty", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colon%2BMalignant%2BTumor", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Post-traumatic%2BAnosmia", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronary%2BArtery%2BDisease", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ultrasound%2BEvaluation", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stroke", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%252C%2BAdrenal%2BCortical", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Cushing%2527s%2BSyndrome%2BI", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Depression", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Breast%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Prostate%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pain", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Brimonidine%2Btartrate%2Bophthalmic%2Bsolution%2B0.025%2525%2B%2528n%2B%253D%2B56%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Valacyclovir%2Barrow", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Pilocarpine%2B1.25%2525%2BEye%2Bdrop", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=MK-8521%2B100%25CE%25BCg", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cyclophosphamide", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Injectafer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Transplant%2B2%2BMelphalan", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Prednisone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Capecitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Bevacizumab", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Carboplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Dexamethasone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Teicoplanin%2BSandoz%2B200%2Bmg%2Bpowder%2Band%2Bsolvent%2Bfor%2Bsolution%2Bfor%2Binjection%2Bor%2Binfusion%2Bor%2Boral%2Bsolution.", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Docetaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Oral%2BGlucose%2BGel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=20mg%2BAzilsartan%2BTablets", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Gemcitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Paclitaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cisplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Alpelisib%2B150%2BMG%2BOral%2BTablet%2B%255BPiqray%255D", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/cro-list/country/bahamas", "https://ichgcp.net/es/cro-list/country/bahrain", "https://ichgcp.net/es/cro-list/country/belarus", "https://ichgcp.net/es/cro-list/country/el_salvador", "https://ichgcp.net/es/cro-list/country/germany", "https://ichgcp.net/es/cro-list/country/malaysia", "https://ichgcp.net/es/cro-list/country/malta", "https://ichgcp.net/es/cro-list/country/mauritius", "https://ichgcp.net/es/cro-list/country/montenegro", "https://ichgcp.net/es/cro-list/country/pakistan", "https://ichgcp.net/es/cro-list/country/senegal", "https://ichgcp.net/es/cro-list/country/spain", "https://ichgcp.net/es/cro-list/country/usa", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/cro-list/country/argentina/company/egcp_sa_excellence_in_good_clinical_practice", "https://ichgcp.net/es/cro-list/country/argentina/company/klixar", "https://ichgcp.net/es/cro-list/country/argentina/company/iqvia", "https://ichgcp.net/es/cro-list/country/argentina/company/pra_health_sciences", "https://ichgcp.net/es/cro-list/country/argentina/company/nergy_health_research", "https://ichgcp.net/es/cro-list/country/argentina/company/parexel", "https://ichgcp.net/es/cro-list/country/argentina/company/syneos_health", "https://ichgcp.net/es/cro-list/country/argentina/company/labcorp_drug_development", "https://ichgcp.net/es/cro-list/country/argentina/company/psi", "https://ichgcp.net/es/cro-list/country/argentina/company/caidya", "https://ichgcp.net/es/cro-list/country/argentina", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/ord_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_cat", "https://ichgcp.net/es", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/guideline-for-the-notification-of-serious-breaches-of-regulation-eu-no-536-2014", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/about-us-our-mission", "https://ichgcp.net/es/sitemap", "https://ichgcp.net/es/contact-us", "https://ichgcp.net/es/feed", "/privacy", "/disclaimer", "https://ichgcp.net/da/clinical-trials-registry/NCT00019006", "https://ichgcp.net/de/clinical-trials-registry/NCT00019006", "https://ichgcp.net/clinical-trials-registry/NCT00019006", "https://ichgcp.net/es/clinical-trials-registry/NCT00019006", "https://ichgcp.net/fr/clinical-trials-registry/NCT00019006", "https://ichgcp.net/it/clinical-trials-registry/NCT00019006", "https://ichgcp.net/hu/clinical-trials-registry/NCT00019006", "https://ichgcp.net/nl/clinical-trials-registry/NCT00019006", "https://ichgcp.net/no/clinical-trials-registry/NCT00019006", "https://ichgcp.net/pl/clinical-trials-registry/NCT00019006", "https://ichgcp.net/pt/clinical-trials-registry/NCT00019006", "https://ichgcp.net/fi/clinical-trials-registry/NCT00019006", "https://ichgcp.net/sv/clinical-trials-registry/NCT00019006", "https://ichgcp.net/cs/clinical-trials-registry/NCT00019006", "https://ichgcp.net/ru/clinical-trials-registry/NCT00019006", "https://ichgcp.net/ja/clinical-trials-registry/NCT00019006", "https://ichgcp.net/zh/clinical-trials-registry/NCT00019006", "https://ichgcp.net/ko/clinical-trials-registry/NCT00019006", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf"]}